Interventional Radiology Market Trends, Growth Drivers, Revenue, Demand and Future Opportunities

Interventional Radiology Market Growth, Size, Trends Analysis - By Product, By Application, By End-Use - Regional Outlook, Competitive Strategies and Segment Forecast to 2034

Published: Feb-2025 Report ID: HLCA2575 Pages: 1 - 220 Formats*:     
Category : Healthcare
Interventional Radiology Market Introduction and Overview

According to SPER Market Research, the Global Interventional Radiology Market is estimated to reach USD 49.54 billion by 2034 with a CAGR of 5.29%.

The report includes an in-depth analysis of the Global Interventional Radiology Market, including market size and trends, product mix, Applications, and supplier analysis. The global interventional radiology market is expanding rapidly, driven primarily by the rising frequency of chronic disorders such as cardiovascular disease and cancer. The growing desire for minimally invasive procedures, which provide less patient discomfort and shorter recovery times than standard surgeries, fuels this expansion. Technological improvements, such as the integration of high-resolution imaging and artificial intelligence, improve diagnostic accuracy and procedural efficiency, contributing to the market's increasing trend. However, challenges remain, most notably the high costs associated with advanced interventional radiology equipment, which might limit access, particularly in resource-constrained areas. Furthermore, an absence of qualified interventional radiologists complicates the general use of these new techniques. Regulatory barriers and compliance difficulties complicate market growth dynamics. 
By Product Insights: The Global Interventional Radiology Market’s product segment is further segmented into 6 categories: Angiography Systems, Ultrasound Imaging Systems, CT Scanners, MRI Systems, Fluoroscopy Systems and Biopsy Devices. The angiography systems segment had the biggest revenue in 2024. Angiography systems are commonly used in interventional radiology to diagnose and treat numerous cardiovascular diseases because they produce detailed images of blood vessels, allowing for accurate navigation during treatments like angioplasty, stent implantation, and embolization. The increasing demand for these systems in both diagnostic and therapeutic applications, combined with ongoing technological improvements that improve picture quality and reduce radiation exposure, has established angiography systems as the market's main product segment.

By Application Insights: The application segment of the Global Interventional Radiology Market is further segmented into 6 categories: Cardiology, Oncology, Gynaecology, Obstetrics, Urology and Gastroenterology. In 2024, the cardiology sector dominated the market, accounting for the highest market share. Cardiovascular diseases (CVDs) are one of the main causes of death worldwide, creating a considerable demand for diagnostic and therapeutic approaches. Interventional radiology treatments such as angioplasty, stenting, and embolization are essential for treating coronary artery disease, stroke, and peripheral vascular disease. Due to the prevalence of these disorders, cardiology is the most common application segment.

By End-Use Insights: The End-Use of the Global Interventional Radiology Market is further segmented into 3 categories: Hospitals, Clinic, Ambulatory Surgical Centres and Others. The hospital industry dominated the market in 2024. Hospitals have the most advanced and extensive infrastructure, including cutting-edge imaging technology and interventional radiology suites. This enables them to execute a wide range of difficult treatments that necessitate specialist equipment, including angioplasty, embolization, and biopsies. Because of their ability to deliver these advanced treatments, hospitals are the preferred location for interventional radiology operations.

By Regional Insights: North Americas interventional radiology market accounted for the most market revenue in 2024 and is expected to expand between 2025 and 2034. North America, particularly the United States, has a high prevalence of chronic illnesses such as cardiovascular disease, cancer, and diabetes, all of which increase demand for interventional radiology operations. There is a high desire for minimally invasive treatments to control these illnesses, which is driving market expansion. Furthermore, North America's superior healthcare infrastructure and advantageous reimbursement regulations support the implementation of innovative interventional radiology technology, which drives market expansion.



Market Competitive Landscape:
Global Interventional Radiology Market is very competitive, with top companies focusing on product innovation, organic certifications, and strategic collaborations to increase market share. Some of the key market players are Agfa-Gevaert Group, Canon Medical Systems Corporation, Carestream Healthcare Inc., Esaote SPA, Fujifilm Corporation, GE Healthcare, Hologic Inc., Samsung Healthcare (Samsung Electronics Co. Ltd.), Siemen Healthineers and Teleflex Incorporated.

Recent Developments:
  • In June 2024, GE HealthCare and MediView XR Inc. have announced the first installation of the OmnifyXR interventional suite at North Star Vascular and Interventional (NSVI) in Minneapolis, MN. This introduction represents a significant expansion of the company's interventional radiology product, and it is intended to extend its customer base.
  • In June 2024, Following FDA approval, Royal Philips reported the first implantation of the Duo Venous Stent System, a device designed to treat symptomatic venous outflow blockage in patients with chronic venous insufficiency (CVI). This milestone is expected to boost the company's market reputation and increase its position in the industry.
Scope of the Report:
 Report Metric Details
 Market size available for years 2021-2034
 Base year considered 2024
 Forecast period 2025-2034
 Segments coveredBy Product, By Application, By End-Use.
 Regions covered
North America, Latin America, Asia-Pacific, Europe, and Middle East & Africa.
 Companies CoveredAgfa-Gevaert Group, Canon Medical Systems Corporation, Carestream Healthcare Inc., Esaote SPA, Fujifilm Corporation, GE Healthcare, Hologic Inc., Samsung Healthcare (Samsung Electronics Co. Ltd.), Siemen Healthineers and Teleflex Incorporated and others.
Key Topics Covered in the Report:
  • Global Interventional Radiology Market Size (FY’2021-FY’2034)
  • Overview of Global Interventional Radiology Market
  • Segmentation of Global Interventional Radiology Market By Product (Angiography Systems, Ultrasound Imaging Systems, CT Scanners, MRI Systems, Fluoroscopy Systems, Biopsy Devices)
  • Segmentation of Global Interventional Radiology Market By Application (Cardiology, Oncology, Gynaecology, Obstetrics, Urology and Gastroenterology)
  • Segmentation of Global Interventional Radiology Market By End Use (Hospitals, Clinic, Ambulatory Surgical Centres, Others)
  • Statistical Snap of Global Interventional Radiology Market
  • Expansion Analysis of Global Interventional Radiology Market
  • Problems and Obstacles in Global Interventional Radiology Market
  • Competitive Landscape in the Global Interventional Radiology Market
  • Details on Current Investment in Global Interventional Radiology Market
  • Competitive Analysis of Global Interventional Radiology Market
  • Prominent Players in the Global Interventional Radiology Market
  • SWOT Analysis of Global Interventional Radiology Market
  • Global Interventional Radiology Market Future Outlook and Projections (FY’2025-FY’2034)
  • Recommendations from Analyst
1. Introduction
1.1. Scope of the report
1.2. Market segment analysis

2. Research Methodology
2.1. Research data source
2.1.1. Secondary Data
2.1.2. Primary Data
2.1.3. SPERs internal database
2.1.4. Premium insight from KOLs
2.2. Market size estimation
2.2.1. Top-down and Bottom-up approach
2.3. Data triangulation

3. Executive Summary

4. Market Dynamics
4.1. Driver, Restraint, Opportunity and Challenges analysis
4.1.1. Drivers
4.1.2. Restraints
4.1.3. Opportunities
4.1.4. Challenges

5. Market variable and outlook
5.1. SWOT Analysis
5.1.1. Strengths
5.1.2. Weaknesses
5.1.3. Opportunities
5.1.4. Threats
5.2. PESTEL Analysis
5.2.1. Political Landscape
5.2.2. Economic Landscape
5.2.3. Social Landscape
5.2.4. Technological Landscape
5.2.5. Environmental Landscape
5.2.6. Legal Landscape
5.3. PORTERs Five Forces 
5.3.1. Bargaining power of suppliers
5.3.2. Bargaining power of buyers
5.3.3. Threat of Substitute
5.3.4. Threat of new entrant
5.3.5. Competitive rivalry
5.4. Heat Map Analysis

6. Competitive Landscape
6.1. Global Interventional Radiology Market Manufacturing Base Distribution, Sales Area, Product Type 
6.2. Mergers & Acquisitions, Partnerships, Product Launch, and Collaboration in Global Interventional Radiology Market

7. Global Interventional Radiology Market, By Product (USD Million) 2021-2034
7.1. Angiography Systems
7.2. Ultrasound Imaging Systems
7.3. CT Scanners
7.4. MRI Systems
7.5. Fluoroscopy Systems
7.6. Biopsy Devices

8. Global Interventional Radiology Market, By Application (USD Million) 2021-2034
8.1. Cardiology
8.2. Oncology
8.3. Gynaecology
8.4. Obstetrics
8.5. Urology
8.6. Gastroenterology

9. Global Interventional Radiology Market, By End-Use (USD Million) 2021-2034
9.1. Hospitals
9.2. Clinics
9.3. Ambulatory Surgical Centres
9.4. Others

10. Global Interventional Radiology Market, (USD Million) 2021-2034
10.1. Global Interventional Radiology Market Size and Market Share

11. Global Interventional Radiology Market, By Region, (USD Million) 2021-2034
11.1. Asia-Pacific
11.1.1. Australia
11.1.2. China
11.1.3. India
11.1.4. Japan
11.1.5. South Korea
11.1.6. Rest of Asia-Pacific
11.2. Europe
11.2.1. France
11.2.2. Germany
11.2.3. Italy
11.2.4. Spain
11.2.5. United Kingdom
11.2.6. Rest of Europe
11.3. Middle East and Africa
11.3.1. Kingdom of Saudi Arabia 
11.3.2. United Arab Emirates
11.3.3. Qatar
11.3.4. South Africa
11.3.5. Egypt
11.3.6. Morocco
11.3.7. Nigeria
11.3.8. Rest of Middle-East and Africa
11.4. North America
11.4.1. Canada
11.4.2. Mexico
11.4.3. United States
11.5. Latin America
11.5.1. Argentina
11.5.2. Brazil
11.5.3. Rest of Latin America 

12. Company Profile
12.1. Agfa-Gevaert Group
12.1.1. Company details
12.1.2. Financial outlook
12.1.3. Product summary 
12.1.4. Recent developments
12.2. Canon Medical Systems Corporation
12.2.1. Company details
12.2.2. Financial outlook
12.2.3. Product summary 
12.2.4. Recent developments
12.3. Carestream Healthcare Inc.
12.3.1. Company details
12.3.2. Financial outlook
12.3.3. Product summary 
12.3.4. Recent developments
12.4. Esaote SPA
12.4.1. Company details
12.4.2. Financial outlook
12.4.3. Product summary 
12.4.4. Recent developments
12.5. Fujifilm Corporation
12.5.1. Company details
12.5.2. Financial outlook
12.5.3. Product summary 
12.5.4. Recent developments
12.6. GE Healthcare
12.6.1. Company details
12.6.2. Financial outlook
12.6.3. Product summary 
12.6.4. Recent developments
12.7. Hologic Inc.
12.7.1. Company details
12.7.2. Financial outlook
12.7.3. Product summary 
12.7.4. Recent developments
12.8. Samsung Healthcare (Samsung Electronics Co. Ltd.)
12.8.1. Company details
12.8.2. Financial outlook
12.8.3. Product summary 
12.8.4. Recent developments
12.9. Siemens Healthineers
12.9.1. Company details
12.9.2. Financial outlook
12.9.3. Product summary 
12.9.4. Recent developments
12.10. Teleflex Incorporated
12.10.1. Company details
12.10.2. Financial outlook
12.10.3. Product summary 
12.10.4. Recent developments
12.11. Others

13. Conclusion

14. List of Abbreviations

15. Reference Links

SPER Market Research’s methodology uses great emphasis on primary research to ensure that the market intelligence insights are up to date, reliable and accurate. Primary interviews are done with players involved in each phase of a supply chain to analyze the market forecasting. The secondary research method is used to help you fully understand how the future markets and the spending patterns look likes.

The report is based on in-depth qualitative and quantitative analysis of the Product Market. The quantitative analysis involves the application of various projection and sampling techniques. The qualitative analysis involves primary interviews, surveys, and vendor briefings.  The data gathered as a result of these processes are validated through experts opinion. Our research methodology entails an ideal mixture of primary and secondary initiatives.

SPER-Methodology-1

SPER-Methodology-2

SPER-Methodology-3


Frequently Asked Questions About This Report
Interventional Radiology Market is projected to reach USD 49.54 billion by 2034, growing at a CAGR of 5.29% during the forecast period.
Interventional Radiology Market grew in Market size from 2025. The Market is expected to reach USD 49.54 billion by 2034, at a CAGR of 5.29% during the forecast period.
Interventional Radiology Market CAGR of 5.29% during the forecast period.
Interventional Radiology Market size is USD 49.54 billion from 2025 to 2034.
Interventional Radiology Market is covered By Product, By Application, By End-Use.
The North America is anticipated to have the highest Market share in the Interventional Radiology Market.
The key players in the Market include Companies Covered Agfa-Gevaert Group, Canon Medical Systems Corporation, Carestream Healthcare Inc., Esaote SPA, Fujifilm Corporation, GE Healthcare, Hologic Inc., Samsung Healthcare (Samsung Electronics Co. Ltd.), Siemen Healthineers and Teleflex Incorporated and others.
The growing desire for minimally invasive procedures, which provide less patient discomfort and shorter recovery times than standard surgeries, fuels this expansion. Technological improvements, such as the integration of high-resolution imaging and artificial intelligence, improve diagnostic accuracy and procedural efficiency, contributing to the market's increasing trend.
PLACE AN ORDER
  • 15 % off
     
    $ 4250
  • 20 % off
             
    $ 5650
  • 25 % off
         
    $ 7450
Pre-Purchase Inquiry
SEND AN INQUIRY
NEED CUSTOMIZATION?
Request Customization
CALL OR EMAIL US
US:
India:
Email:
100% Secure Payment

SPER American Express
SPER VISA
SPER Master Card
SPER Mestro
SPER Paypal
SPER CCAvenues

Have a glance of the Report

  Download Free Sample

Looking for Customization?

 Customization Request

Have a Question?

 Reach Our Analysis Team

COVID-19 impact analysis?

 Request Analysis

Our Global Clients

Our data-driven insights have influenced the strategy of 200+ reputed companies across the globe.

SPER-Astellas Pharma
SPER-Microsoft
SPER-EY
SPER-McKinsey
SPER-Bain
SPER-Max-Healthcare
SPER-DHL
SPER-IQVIA
SPER-Mitsubishi Logistics
SPER-PACCOR
SPER-Macmillan Education
SPER-Kankar IMRB
SPER-ITA
SPER-PWC
SPER-SAPTCA
SPER-Straumann
SPER-MENARINI Silicon Biosystems
SPER-IPSOS
SPER-Heineken

GDPR
Complaint

ISO 27001, 20252 & 9001
Certified